Altman Advisors’s Medtronic MDT Stock Holding History

Altman Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,744	Closed	-$2.31K	–	83
2018 Q2	$2.31K	Buy	+14,744	New	+$1.23M	2.12%	15

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Altman Advisors's MDT Position: Q3 2018 in Review

Altman Advisors sold out of Medtronic (MDT) in Q3 2018, closing a stake of 14,744 shares — an estimated $2.31K sold.

Altman Advisors first reported a position in MDT in Q2 2018 and held it in 1 quarter. The position peaked at $2.31K in Q2 2018. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

Altman Advisors reported no remaining Medtronic position as of Q3 2018 after selling out during the quarter.
Altman Advisors sold 14,744 Medtronic shares in Q3 2018, an estimated $2.31K.
Altman Advisors first reported a position in Medtronic in Q2 2018 and held it in 1 quarter.
Altman Advisors's Medtronic position peaked at $2.31K in Q2 2018.
1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on Altman Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.